Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?

Author： Liapakis AnnMarie   Jesudian Arun B  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.12, 2012-09, pp. : 1317-1319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clevudine for the treatment of chronic hepatitis B virus infection

By Hui Chee-Kin   Lau George KK  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1277-1284

Informa Healthcare

Access to resources Recommend Favorite

IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population

By  

Journal of Digestive Diseases, Vol. 16, Iss. 2, 2015-02 ,pp. : 90-97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evolving therapies for the treatment of chronic hepatitis B virus infection

By IV William E Delaney   Bartholomeusz Angeline   Locarnini Stephen A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 2, 2002-02 ,pp. : 169-187

Informa Healthcare

Access to resources Recommend Favorite

NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection

By Herbst D Alan   Reddy K Rajender  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1337-1346

Informa Healthcare

Access to resources Recommend Favorite

Impact of IL28B SNPs on therapeutic outcome and liver histology differs between hepatitis C virus genotypes

By Lagging Martin  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 847-849

Future Medicine

Access to resources Recommend Favorite